US 8557245
Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 8557245 (Methods for treating bone cancer by administering a nerve growth factor antagonist antibody) held by Regents of the University of Minnesota expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61P, A61P11/00